Press "Enter" to skip to content

Analysis of Blood Glucose Monitoring Market 2019-2024: Industry Trends, Share, Size, Price, Revenue, Business Strategy, Production Technology Forecast to 2024

Blood

The “Blood Glucose Monitoring Market” research report 2019-2024 delivers comprehensive information and valuable insights about the Blood Glucose Monitoring industry. The information available in the Blood Glucose Monitoring market report is not only based on the facts but also on the case studies, which analysts have included to convey appropriate information to the clients in a well-versed manner. Blood Glucose Monitoring market report includes valuable information to assist new entrants, as well as established players, to understand the prevailing trends in the market.

Some Companies Are Covered in the Blood Glucose Monitoring Market:

  • Abbott Diabetes Care
  • Roche
  • Johnson & Johnson
  • Dexcom
  • Medtronic
  • Arkray
  • Ascensia Diabetes Care
  • Agamatrix Inc.
  • Bionime Corporation
  • Acon
  • Medisana
  • Trivida
  • Rossmax

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14245404

    Market Overview:

  • The global blood glucose monitoring market is expected to register a CAGR of 11.88% during the forecast period of 2019 – 2024; the market is estimated to reach USD 12.8 billion by 2019.
  • Blood glucose monitoring devices are used for effective diabetes diagnosis and treatment. A rise in the diabetic population drives the market by increasing the use of blood glucose monitoring devices.
  • Obesity is also considered as one of the major factors contributing to the disease, primarily Type 2 diabetes.
  • Also, other factors, such as technological innovations and advancements, give much convenience in measuring the blood glucose levels. One such advancement in monitoring the blood glucose level is established with continuous glucose monitoring devices.
  • These devices help in the early detection of hypo and hyperglycemic conditions, which tend to drive the market for glucose monitoring.

    Scope of the Report:

  • There are two main types of blood glucose monitoring devices included in this study, namely the self monitoring blood glucose devices and the continuous glucose monitoring devices. The devices are further categorized by components, i.e. the self-monitoring blood glucose (SMBG) devices are segmented into glucometer devices, test strips, and lancets (which are further studied by their usage in hospital and home individually) and continuous glucose monitoring (CGM) devices are segmented into sensors and receivers.

    Reasons for Buying Blood Glucose Monitoring Market Report:

    • This report provides pin-point analysis for changing competitive dynamics
    • It provides a forward looking perspective on different factors driving or restraining market growth
    • It provides a five-year forecast assessed on the basis of how the market is predicted to grow
    • It helps in understanding the key product segments and their future
    • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/14245404

    Key Market Trends: – Glucometer consumables (test strips and lancets) occupy the highest market share

    Although CGM is an advanced way for people living with diabetes to check glucose readings in real-time, SMBG is the most preferred device by the patients due to its economic affordability and less sophisticated usage when compared to CGM. The SBGM occupies more than 87% of the share in the blood glucose monitoring market. The further segmented market of SBGM gives an understanding that the disposable consumables – test strips and lancets, occupy the larger market share when compared to glucometer devices. However, the CAGR for glucometer devices is high.
    CGM, though it provides real-time data of blood glucose levels for patients, has low adaptability in the emerging markets. However, CGM’s adaptability is high in developed markets. The cost factor is a major concern for the low growth of CGM in emerging markets.

    North America is leading the market

    In 2018, North America, especially the United States, held the largest share in the blood glucose monitoring market, due to the large patient pool and wide acceptance of advanced technologies followed by Europe, which showed moderate growth. Asia-Pacific, Latin America, and the Middle East & Africa showed low growth due to economic affordability.

    Blood Glucose Monitoring Market Report Provides Comprehensive Analysis of:

    • Functional market industry outline
    • Up and downstream industry examination
    • Channels and propositions believability
    • Market challenge by key players
    • Enhancement suggestions examination

    Purchase this Report (Price 5000 USD for single user license) – https://www.industryresearch.co/purchase/14245404

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    Detailed TOC of Blood Glucose Monitoring Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Drivers
    4.3 Restraints
    4.4 Porter’s Five Forces Analysis
    4.4.1 Bargaining Power of Suppliers
    4.4.2 Bargaining Power of Consumers
    4.4.3 Threat of New Entrants
    4.4.4 Threat of Substitute Products and Services
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 Blood Glucose Monitoring
    5.1.1 Self-Monitoring Blood Glucose
    5.1.1.1 By Component (Market Size, Value and Volume)
    5.1.1.1.1 Glucometer Devices
    5.1.1.1.2 Test Strips
    5.1.1.1.3 Lancets
    5.1.1.2 By End User
    5.1.1.2.1 Hospital (Market Size, Value and Volume)
    5.1.1.2.1.1 Glucometer Devices
    5.1.1.2.1.2 Test Strips
    5.1.1.2.1.3 Lancets
    5.1.1.2.2 Personal (Market Size, Value and Volume)
    5.1.1.2.2.1 Glucometer Devices
    5.1.1.2.2.2 Test Strips
    5.1.1.2.2.3 Lancets
    5.1.2 Continuous Blood Glucose Monitoring
    5.1.2.1 By Component (Market Size, Value and Volume)
    5.1.2.1.1 Sensors
    5.1.2.1.2 Receivers
    5.2 Geography
    5.2.1 North America
    5.2.1.1 United States (Market Size, Value and Volume)
    5.2.1.1.1 Self-Monitoring Blood Glucose
    5.2.1.1.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.1.1.1.2 By End User (Hospital and Home)
    5.2.1.1.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.1.1.2 Continuous Glucose Monitoring
    5.2.1.1.2.1 By Component (Sensors and Receivers)
    5.2.1.1.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.1.2 Canada (Market Size, Value and Volume)
    5.2.1.2.1 Self-Monitoring Blood Glucose
    5.2.1.2.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.1.2.1.2 By End User (Hospital and Home)
    5.2.1.2.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.1.2.2 Continuous Glucose Monitoring
    5.2.1.2.2.1 By Component (Sensors and Receivers)
    5.2.1.2.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.1.3 Rest of North America (Market Size, Value and Volume)
    5.2.1.3.1 Self-Monitoring Blood Glucose
    5.2.1.3.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.1.3.1.2 By End User (Hospital and Home)
    5.2.1.3.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.1.3.2 Continuous Glucose Monitoring
    5.2.1.3.2.1 By Component (Sensors and Receivers)
    5.2.1.3.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.2 Europe
    5.2.2.1 France (Market Size, Value and Volume)
    5.2.2.1.1 Self-Monitoring Blood Glucose
    5.2.2.1.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.2.1.1.2 By End User (Hospital and Home)
    5.2.2.1.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.2.1.2 Continuous Glucose Monitoring
    5.2.2.1.2.1 By Component (Sensors and Receivers)
    5.2.2.1.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.2.2 Germany (Market Size, Value and Volume)
    5.2.2.2.1 Self-Monitoring Blood Glucose
    5.2.2.2.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.2.2.1.2 By End User (Hospital and Home)
    5.2.2.2.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.2.2.2 Continuous Glucose Monitoring
    5.2.2.2.2.1 By Component (Sensors and Receivers)
    5.2.2.2.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.2.3 Italy (Market Size, Value and Volume)
    5.2.2.3.1 Self-Monitoring Blood Glucose
    5.2.2.3.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.2.3.1.2 By End User (Hospital and Home)
    5.2.2.3.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.2.3.2 Continuous Glucose Monitoring
    5.2.2.3.2.1 By Component (Sensors and Receivers)
    5.2.2.3.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.2.4 Spain (Market Size, Value and Volume)
    5.2.2.4.1 Self-Monitoring Blood Glucose
    5.2.2.4.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.2.4.1.2 By End User (Hospital and Home)
    5.2.2.4.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.2.4.2 Continuous Glucose Monitoring
    5.2.2.4.2.1 By Component (Sensors and Receivers)
    5.2.2.4.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.2.5 United Kingdom (Market Size, Value and Volume)
    5.2.2.5.1 Self-Monitoring Blood Glucose
    5.2.2.5.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.2.5.1.2 By End User (Hospital and Home)
    5.2.2.5.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.2.5.2 Continuous Glucose Monitoring
    5.2.2.5.2.1 By Component (Sensors and Receivers)
    5.2.2.5.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.2.6 Russia (Market Size, Value and Volume)
    5.2.2.6.1 Self-Monitoring Blood Glucose
    5.2.2.6.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.2.6.1.2 By End User (Hospital and Home)
    5.2.2.6.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.2.6.2 Continuous Glucose Monitoring
    5.2.2.6.2.1 By Component (Sensors and Receivers)
    5.2.2.6.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.2.7 Rest of Europe (Market Size, Value and Volume)
    5.2.2.7.1 Self-Monitoring Blood Glucose
    5.2.2.7.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.2.7.1.2 By End User (Hospital and Home)
    5.2.2.7.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.2.7.2 Continuous Glucose Monitoring
    5.2.2.7.2.1 By Component (Sensors and Receivers)
    5.2.2.7.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.3 Latin America
    5.2.3.1 Mexico (Market Size, Value and Volume)
    5.2.3.1.1 Self-Monitoring Blood Glucose
    5.2.3.1.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.3.1.1.2 By End User (Hospital and Home)
    5.2.3.1.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.3.1.2 Continuous Glucose Monitoring
    5.2.3.1.2.1 By Component (Sensors and Receivers)
    5.2.3.1.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.3.2 Brazil (Market Size, Value and Volume)
    5.2.3.2.1 Self-Monitoring Blood Glucose
    5.2.3.2.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.3.2.1.2 By End User (Hospital and Home)
    5.2.3.2.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.3.2.2 Continuous Glucose Monitoring
    5.2.3.2.2.1 By Component (Sensors and Receivers)
    5.2.3.2.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.3.3 Rest of Latin America (Market Size, Value and Volume)
    5.2.3.3.1 Self-Monitoring Blood Glucose
    5.2.3.3.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.3.3.1.2 By End User (Hospital and Home)
    5.2.3.3.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.3.3.2 Continuous Glucose Monitoring
    5.2.3.3.2.1 By Component (Sensors and Receivers)
    5.2.3.3.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.4 Asia-Pacific
    5.2.4.1 Japan (Market Size, Value and Volume)
    5.2.4.1.1 Self-Monitoring Blood Glucose
    5.2.4.1.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.4.1.1.2 By End User (Hospital and Home)
    5.2.4.1.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.1.2 Continuous Glucose Monitoring
    5.2.4.1.2.1 By Component (Sensors and Receivers)
    5.2.4.1.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.4.2 South Korea (Market Size, Value and Volume)
    5.2.4.2.1 Self-Monitoring Blood Glucose
    5.2.4.2.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.4.2.1.2 By End User (Hospital and Home)
    5.2.4.2.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.2.2 Continuous Glucose Monitoring
    5.2.4.2.2.1 By Component (Sensors and Receivers)
    5.2.4.2.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.4.3 China (Market Size, Value and Volume)
    5.2.4.3.1 Self-Monitoring Blood Glucose
    5.2.4.3.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.4.3.1.2 By End User (Hospital and Home)
    5.2.4.3.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.3.2 Continuous Glucose Monitoring
    5.2.4.3.2.1 By Component (Sensors and Receivers)
    5.2.4.3.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.4.4 India (Market Size, Value and Volume)
    5.2.4.4.1 Self-Monitoring Blood Glucose
    5.2.4.4.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.4.4.1.2 By End User (Hospital and Home)
    5.2.4.4.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.4.2 Continuous Glucose Monitoring
    5.2.4.4.2.1 By Component (Sensors and Receivers)
    5.2.4.4.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.4.5 Australia (Market Size, Value and Volume)
    5.2.4.5.1 Self-Monitoring Blood Glucose
    5.2.4.5.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.4.5.1.2 By End User (Hospital and Home)
    5.2.4.5.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.5.2 Continuous Glucose Monitoring
    5.2.4.5.2.1 By Component (Sensors and Receivers)
    5.2.4.5.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.4.6 Vietnam (Market Size, Value and Volume)
    5.2.4.6.1 Self-Monitoring Blood Glucose
    5.2.4.6.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.4.6.1.2 By End User (Hospital and Home)
    5.2.4.6.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.6.2 Continuous Glucose Monitoring
    5.2.4.6.2.1 By Component (Sensors and Receivers)
    5.2.4.6.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.4.7 Malaysia (Market Size, Value and Volume)
    5.2.4.7.1 Self-Monitoring Blood Glucose
    5.2.4.7.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.4.7.1.2 By End User (Hospital and Home)
    5.2.4.7.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.7.2 Continuous Glucose Monitoring
    5.2.4.7.2.1 By Component (Sensors and Receivers)
    5.2.4.7.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.4.8 Indonesia (Market Size, Value and Volume)
    5.2.4.8.1 Self-Monitoring Blood Glucose
    5.2.4.8.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.4.8.1.2 By End User (Hospital and Home)
    5.2.4.8.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.8.2 Continuous Glucose Monitoring
    5.2.4.8.2.1 By Component (Sensors and Receivers)
    5.2.4.8.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.4.9 Philippines (Market Size, Value and Volume)
    5.2.4.9.1 Self-Monitoring Blood Glucose
    5.2.4.9.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.4.9.1.2 By End User (Hospital and Home)
    5.2.4.9.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.9.2 Continuous Glucose Monitoring
    5.2.4.9.2.1 By Component (Sensors and Receivers)
    5.2.4.9.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.4.10 Thailand (Market Size, Value and Volume)
    5.2.4.10.1 Self-Monitoring Blood Glucose
    5.2.4.10.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.4.10.1.2 By End User (Hospital and Home)
    5.2.4.10.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.10.2 Continuous Glucose Monitoring
    5.2.4.10.2.1 By Component (Sensors and Receivers)
    5.2.4.10.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.4.11 Rest of Asia-Pacific (Market Size, Value and Volume)
    5.2.4.11.1 Self-Monitoring Blood Glucose
    5.2.4.11.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.4.11.1.2 By End User (Hospital and Home)
    5.2.4.11.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.11.2 Continuous Glucose Monitoring
    5.2.4.11.2.1 By Component (Sensors and Receivers)
    5.2.4.11.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.5 Middle East and Africa
    5.2.5.1 Saudi Arabia (Market Size, Value and Volume)
    5.2.5.1.1 Self-Monitoring Blood Glucose
    5.2.5.1.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.5.1.1.2 By End User (Hospital and Home)
    5.2.5.1.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.5.1.2 Continuous Glucose Monitoring
    5.2.5.1.2.1 By Component (Sensors and Receivers)
    5.2.5.1.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.5.2 Iran (Market Size, Value and Volume)
    5.2.5.2.1 Self-Monitoring Blood Glucose
    5.2.5.2.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.5.2.1.2 By End User (Hospital and Home)
    5.2.5.2.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.5.2.2 Continuous Glucose Monitoring
    5.2.5.2.2.1 By Component (Sensors and Receivers)
    5.2.5.2.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.5.3 Egypt (Market Size, Value and Volume)
    5.2.5.3.1 Self-Monitoring Blood Glucose
    5.2.5.3.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.5.3.1.2 By End User (Hospital and Home)
    5.2.5.3.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.5.3.2 Continuous Glucose Monitoring
    5.2.5.3.2.1 By Component (Sensors and Receivers)
    5.2.5.3.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.5.4 Oman (Market Size, Value and Volume)
    5.2.5.4.1 Self-Monitoring Blood Glucose
    5.2.5.4.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.5.4.1.2 By End User (Hospital and Home)
    5.2.5.4.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.5.4.2 Continuous Glucose Monitoring
    5.2.5.4.2.1 By Component (Sensors and Receivers)
    5.2.5.4.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.5.5 South Africa (Market Size, Value and Volume)
    5.2.5.5.1 Self-Monitoring Blood Glucose
    5.2.5.5.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.5.5.1.2 By End User (Hospital and Home)
    5.2.5.5.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.5.5.2 Continuous Glucose Monitoring
    5.2.5.5.2.1 By Component (Sensors and Receivers)
    5.2.5.5.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.5.6 Rest of Middle and Africa (Market Size, Value and Volume)
    5.2.5.6.1 Self-Monitoring Blood Glucose
    5.2.5.6.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.5.6.1.2 By End User (Hospital and Home)
    5.2.5.6.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.5.6.2 Continuous Glucose Monitoring
    5.2.5.6.2.1 By Component (Sensors and Receivers)
    5.2.5.6.2.2 By Company (Dexcom, Abbott, Medtronic and Others)

    6 MARKET INDICATORS
    6.1 Type-1 Diabetes population (2013-2024)
    6.2 Type-2 Diabetes population (2013-2024)

    7 COMPETITIVE LANDSCAPE
    7.1 COMPANY PROFILES
    7.1.1 Abbott Diabetes Care
    7.1.2 Roche
    7.1.3 Johnson & Johnson
    7.1.4 Dexcom
    7.1.5 Medtronic
    7.1.6 Arkray
    7.1.7 Ascensia Diabetes Care
    7.1.8 Agamatrix Inc.
    7.1.9 Bionime Corporation
    7.1.10 Acon
    7.1.11 Medisana
    7.1.12 Trivida
    7.1.13 Rossmax
    7.2 COMPANY SHARE ANALYSIS
    7.2.1 Roche
    7.2.2 Johnson & Johnson
    7.2.3 Abbott Diabetes Care
    7.2.4 Dexcom
    7.2.5 Medtronic
    7.2.6 Others

    8 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Global Welded Hydraulic Cylinder Market 2019 Overview By Industry Size, Explosive Growth Factors, Emerging Demand, Current Trends, Company Profiles, Competitive Landscape and Forecasts till 2024

    Vanilla Powder Market 2019: Global Size, Industry Share, Outlook, Trends Evaluation, Geographical Segmentation, Business Challenges and Opportunity Analysis till 2023,

    Customer Experience Software Market 2019 – Global Industry Scope, Competition Strategies, Gross Margin Analysis by Size & Share, and Forecast to 2023

    BioPhotonics Market 2019 – Global Industry Analysis, Size, Share, Growth, Trends, Key Players and Forecast 2019 – 2024

  • Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *